miR-34c Targets MET to Improve the Anti-Tumor Effect of Cisplatin on Ovarian Cancer

BACKGROUND: Cisplatin is a commonly used drug for the treatment of various types of malignant cancers, including ovarian cancer. However, resistance to cisplatin is still a considerable obstacle to achieve a satisfactory therapeutic effect. The purpose of this study is to develop a strategy to sensi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Shiying, Li, Zhen, Luo, Rui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7148417/
https://www.ncbi.nlm.nih.gov/pubmed/32308421
http://dx.doi.org/10.2147/OTT.S239425

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7148417/
https://www.ncbi.nlm.nih.gov/pubmed/32308421
http://dx.doi.org/10.2147/OTT.S239425

Ejemplares similares